Drug Database
PA

paliperidone

✓ Approved

Torrent Pharmaceuticals Limited · DRD2 · Small Molecule

What is paliperidone?

paliperidone is a small molecule developed by Torrent Pharmaceuticals Limited. It is approved for therapeutic indications via oral (po).

Drug Profile

CompanyTorrent Pharmaceuticals Limited
Drug ClassSmall Molecule
Molecular TargetDRD2, HTR2A, HTR7
RouteOral (PO)
StatusApproved
Sources: ClinicalTrials.gov, Torrent Pharmaceuticals Limited

Mechanism of Action

Molecular Targets

paliperidone acts on 3 molecular targets:

DRD2dopamine receptor D2 (D2DR, D2R)
HTR2A5-hydroxytryptamine receptor 2A (5-HT2A, HTR2)
HTR75-hydroxytryptamine receptor 7 (5-HT7)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

paliperidone is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Psychiatric disordersSchizophrenia✓ Approved

Related Research Articles

Unable to load articles right now.

Ask about paliperidone